Choice of Initial Oral Therapy for Pulmonary Arterial Hypertension: Age and Long-Term Survival
Choice of Initial Oral Therapy for Pulmonary Arterial Hypertension: Age and Long-Term Survival
About this item
Full title
Author / Creator
Publisher
United States: American Thoracic Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: American Thoracic Society
Subjects
More information
Scope and Contents
Contents
[...]comparative long-term survival outcome data are lacking, and the specific drug choice remains controversial. [...]we aimed to determine which initial oral treatment is associated with better long-term survival. There was no difference between groups in time to clinical worsening (defined as death, lung transplant, or PAH hospitalization) in th...
Alternative Titles
Full title
Choice of Initial Oral Therapy for Pulmonary Arterial Hypertension: Age and Long-Term Survival
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6221567
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6221567
Other Identifiers
ISSN
1073-449X
E-ISSN
1535-4970
DOI
10.1164/rccm.201801-0059LE
